Filing Details
- Accession Number:
- 0001651308-21-000197
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-28 17:48:31
- Reporting Period:
- 2021-09-24
- Accepted Time:
- 2021-09-28 17:48:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509745 | Leap Therapeutics Inc. | LPTX | Pharmaceutical Preparations (2834) | 274412575 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651308 | Beigene, Ltd. | C/O Mourant Governance Services (Cayman) 94 Solaris Avenue, Camana Bay Grand Cayman KY1-1108 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-24 | 2,543,800 | $2.85 | 7,348,437 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On September 24, 2021, BeiGene, Ltd. purchased 2,543,800 shares of common stock of the Issuer for $2.85 per share pursuant to an underwritten public offering.
Billionaire Hedge Funds
